Live feed
Filing
SC 13G/A
SC 13G/A0001033427-17-000017·HALOZYME THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Halozyme Therapeutics Inc
Security class unavailable · CUSIP: 40637H109
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 18,426,928
- Percent of class
- 14.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001033427-17-000017
- Form type
- SC 13G/A
- Filer
- HALOZYME THERAPEUTICS, INC.
- CIK
- CIK 1159036
- Filed
- Feb 02, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership